Unlike their wild-type controls, Batf3−/− mice failed to reject syngeneic fibrosarcomas, did not develop tumor-specific CTLs, and showed reduced numbers of tumor-infiltrating CD8+ T cells (104). This evidence concerns the gene CD8A and fibrosarcoma.